Skip to menu Skip to content Skip to footer

2023

Conference Publication

Bivalent kappa-selective opioid peptides with enhanced metabolic stability and potency

Saifuddin, D., Lohman, R.-J., Tupally, K., Parekh, H. and Cabot, P. (2023). Bivalent kappa-selective opioid peptides with enhanced metabolic stability and potency. 81st FIP World Congress Of Pharmacy And Pharmaceutical Sciences, Brisbane, QLD Australia, 24-28 September 2023. PKP Publishing.

Bivalent kappa-selective opioid peptides with enhanced metabolic stability and potency

2021

Conference Publication

Novel opioid peptides as allosteric modulators of nociception

Saifuddin, Danial, Lohman, Rink-Jan, Tupally, Karnaker Reddy, Parekh, Harendra S. and Cabot, Peter J. (2021). Novel opioid peptides as allosteric modulators of nociception. ASMR medical research week: Queensland virtual symposium, Online, 9-10 June 2021.

Novel opioid peptides as allosteric modulators of nociception

2018

Conference Publication

PAR-2 does not contribute to tubular damage or renal fibrosis in the obstructed kidney

Han, Y., Ma, F., Ozols, E., Chew, P., Vesey, D., Gobe, G., Morais, C., Lohman, R., Suen, J., Fairlie, D. and Nikolic-Paterson, D. (2018). PAR-2 does not contribute to tubular damage or renal fibrosis in the obstructed kidney. 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, Australia, 8–12 September 2018. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.13441

PAR-2 does not contribute to tubular damage or renal fibrosis in the obstructed kidney

2016

Conference Publication

Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signalling

Owens, E., Iyer, A., Morais, C., Lohman, R., Suen, J., Johnson, D., Nikolic-Paterson, D., Gobe, G., Fairlie, D. and Vesey, D. (2016). Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signalling. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth Western Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12887

Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signalling

2016

Conference Publication

Pharmacological Inhibition of Protease-Activated Receptor 2 (Par2) Reduces Crescent Formation in Rat Anti-Gbm Disease

Tesch, G., Han, Y., Vesey, D., Gobe, G., Lohman, R., Suen, J., Fairlie, D. and Nikolic-Paterson, D. (2016). Pharmacological Inhibition of Protease-Activated Receptor 2 (Par2) Reduces Crescent Formation in Rat Anti-Gbm Disease. 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12887

Pharmacological Inhibition of Protease-Activated Receptor 2 (Par2) Reduces Crescent Formation in Rat Anti-Gbm Disease

2015

Conference Publication

Cyclic penta- and hexa leucine peptides without N-methylation are orally absorbed

Kok, Woan Mei, Hill, Timothy A., Lohman, Rink-Jan, Hoang, Huy N., Nielsen, Daniel S., Scully, Conor G., Schroeder, Christina I., Colless, Barbara, Bernhardt, Paul V., Edmonds, David, Griffith, David, Rotter, Charles, Ruggeri, Roger, Price, David, Liras, Spiros, Craik, David and Fairlie, David (2015). Cyclic penta- and hexa leucine peptides without N-methylation are orally absorbed. American Chemical Society Meeting, x, 2015. Washington, DC United States: American Chemical Society.

Cyclic penta- and hexa leucine peptides without N-methylation are orally absorbed

2015

Conference Publication

Downsizing Proteins Without Losing Potency or Function

Fairlie, David P. , Yau, Mei-Kwan , Hamidon, Johan K. , Singh, Ranee , Lim, Junxian , Suen, Jacky Y. , Rowley, Jessica A. , Lohman, Rink-Jan , Stoermer, Martin J. , Iyer, Abishek and Reid, Robert C. (2015). Downsizing Proteins Without Losing Potency or Function. American Peptide Symposium 2015, Orlando , Florida, United States, 20-25 June 2015. American Peptide Society. doi: 10.17952/24APS.2015.016

Downsizing Proteins Without Losing Potency or Function

2013

Conference Publication

Toward more orally bioavailable inhibitors of phospholipase A(2) GIIA (pla2g2a) to treat chronic inflammation

Barbero, Sheila, Reid, Robert C., Stoermer, Martin J., Lohman, Rink J. and Fairlie, David P. (2013). Toward more orally bioavailable inhibitors of phospholipase A(2) GIIA (pla2g2a) to treat chronic inflammation. 246th National Meeting of the American-Chemical-Society (ACS), Indianapolis, IN, United States, 8-12 September 2013. Washington, DC, United States: American Chemical Society.

Toward more orally bioavailable inhibitors of phospholipase A(2) GIIA (pla2g2a) to treat chronic inflammation

2011

Conference Publication

Towards orally bioavailable peptides and peptidomimetics

Fairlie, David P., Stoermer, Martin, Lucke, Andrew, Lohman, Rink-Jan, Liu, Ligong and Ruiz-Gomez, Gloria (2011). Towards orally bioavailable peptides and peptidomimetics. 241st National Meeting and Exposition of the American-Chemical-Society (ACS), Anaheim, CA, United States, 27-31 March 2011. Washington, DC, United States: American Chemical Society.

Towards orally bioavailable peptides and peptidomimetics

2011

Conference Publication

Novel agonists and antagonists for protease activated receptor 2

Yau, Annika M., Liu, Ligong, Reid, Robert C., Barry, Grant D., Suen, Jacky Y., Lohman, Rink-Jan, Le, Giang T., Cotterell, Adam and Fairlie, David P. (2011). Novel agonists and antagonists for protease activated receptor 2. National Meeting of the American Chemical Society (242nd, ACS, 2011), Denver, CO, U.S.A., 28 August-1 September 2011. WASHINGTON: AMER CHEMICAL SOC.

Novel agonists and antagonists for protease activated receptor 2

2009

Conference Publication

Regulating protein and peptide activated GPCRs

Fairlie, David P., Madala, Praveen K., Stoermer, Martin J., Suen, Jacky, Barry, Grant and Lohman, Rink-Jan (2009). Regulating protein and peptide activated GPCRs. 229th National Meeting of the American Chemical Society, San Diego, California, 13-17 March 2005. Washington DC, United States: American Chemical Society.

Regulating protein and peptide activated GPCRs

2005

Conference Publication

Carbamazepine aggravates absence seizures in GAERS rats by acting on the ventrobasalthalamus via a GABA-A mediated mechanism

O'Brien, TJ, Liu, LG, Wallengren, L, Lohman, RJ and Morris, MJ (2005). Carbamazepine aggravates absence seizures in GAERS rats by acting on the ventrobasalthalamus via a GABA-A mediated mechanism. Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society, Washington Dc, Dec 02-06, 2005. OXFORD: BLACKWELL PUBLISHING.

Carbamazepine aggravates absence seizures in GAERS rats by acting on the ventrobasalthalamus via a GABA-A mediated mechanism

2004

Conference Publication

Specific fast oscillatory thalamocortical activity in brain slices in the gaers absence epilepsy model

Myers, DE, O'Brien, TJ, Reid, CA, Adams, BE, Lohman, RJ, Berkovic, S and Williams, DA (2004). Specific fast oscillatory thalamocortical activity in brain slices in the gaers absence epilepsy model. Annual Meeting of the American-Epilepsy-Society, New Orlands La, Dec 03-07, 2004. MALDEN: BLACKWELL PUBLISHING INC.

Specific fast oscillatory thalamocortical activity in brain slices in the gaers absence epilepsy model

2004

Conference Publication

Neuronal activation in the thalamic reticular nucleus correlates with seizure burden but not carbamazepine treatment in a rat model of absence epilepsy

Wallengren, CM, Morris, MJ, Li, S, Lohman, R, Jupp, B and OBrien, TJ (2004). Neuronal activation in the thalamic reticular nucleus correlates with seizure burden but not carbamazepine treatment in a rat model of absence epilepsy. Annual Meeting of the American-Epilepsy-Society, New Orlands La, Dec 03-07, 2004. MALDEN: BLACKWELL PUBLISHING INC.

Neuronal activation in the thalamic reticular nucleus correlates with seizure burden but not carbamazepine treatment in a rat model of absence epilepsy

2004

Conference Publication

Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE

Taher, T, Salzberg, M, Morris, M, Lohman, RJ, Jupp, B and O'Brien, TJ (2004). Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE. Annual Meeting of the American-Epilepsy-Society, New Orlands La, Dec 03-07, 2004. MALDEN: BLACKWELL PUBLISHING INC.

Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE

2004

Conference Publication

GABA receptor subunit and neuropeptide-Y expression do not differ in brains of rats with genetic absence-like epilepsy compared with nonepileptic control rats

Li, S, Wallengren, CM, Lohman, R, Morris, MJ and OBrien, TJ (2004). GABA receptor subunit and neuropeptide-Y expression do not differ in brains of rats with genetic absence-like epilepsy compared with nonepileptic control rats. Annual Meeting of the American-Epilepsy-Society, New Orlands La, Dec 03-07, 2004. MALDEN: BLACKWELL PUBLISHING INC.

GABA receptor subunit and neuropeptide-Y expression do not differ in brains of rats with genetic absence-like epilepsy compared with nonepileptic control rats